H
-
Welcome to Hair loss Experiences hair loss forum.
Free impartial hair loss advice, hair transplant advice, hair loss medications and hair loss news.
You can contact us directly at [email protected] if you experience any problems.
H
habemus
Valued member
. Foitzik K, Hoting E, Heinrich U, Tronnier H, Paus R (2007) Indications that
topical L-carnitin-L-tartrate promotes human hair growth in vivo. J Dermatol
Sci 48: 141-144.
7. de Lacharrière O, Deloche C, Misciali C, Piraccini BM, Vincenzi C, et al. (2001)
Hair diameter diversity: a clinical sign reflecting the follicle miniaturization. Arch
Dermatol 137: 641-646.
8. Stenn KS, Eilertsen K (1996) Molecular basis of hair growth control. J Invest
Dermatol 107: 669-670.
9. Chang CH, Tsai RK, Yu HS (2005) Apoptosis coordinates with proliferation
and differentiation during human hair follicle morphogenesis. J Dermatol Sci
39: 9-16.
10. Winiarska A, Mandt N, Kamp H, Hossini A, Seltmann H, et al. (2006) Effect of
5alpha-dihydrotestosterone and testosterone on apoptosis in human dermal
papilla cells. Skin Pharmacol Physiol 19: 311-321.
11. Foitzik K, Hoting E, Förster T, Pertile P, Paus R (2007) L-carnitine-L-tartrate
promotes human hair growth in vitro. Exp Dermatol 16: 936-945.
12. Hibino T, Nishiyama T (2004) Role of TGF-beta2 in the human hair cycle. J
Dermatol Sci 35: 9-18.
13. Teraki Y, Shiohara T (1999) Apoptosis and the skin. Eur J Dermatol 9: 413-425.
14. Yunis JJ, Oken MM, Kaplan ME, Ensrud KM, Howe RR, et al. (1982) Distinctive
chromosomal abnormalities in histologic subtypes of non-Hodgkin s lymphoma.
N Engl J Med 307: 1231-1236.
15. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, et al. (1985)
Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering
around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:
899-906.
16. Cleary ML, Smith SD, Sklar J (1986) Cloning and structural analysis of cDNAs
for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18)
translocation. Cell 47: 19-28.
17. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM (1984) Cloning of the
chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome
translocation. Science 226: 1097-1099.
18. Jiang X, Wang X (2000) Cytochrome c promotes caspase-9 activation by
inducing nucleotide binding to Apaf-1. J Biol Chem 275: 31199-31203.
19. Cucé LC, C.J.a.R.C., Cellium GC (2011) evaluation of a new natural active
ingredient in 210 mg/ml topical solution, through scalp biopsy. Surg Cosmet
Dermatol 3: 123-128.
20. Trüeb RM (2002) Molecular mechanisms of androgenetic alopecia. Exp
Gerontol 37: 981-990.
21. Kaplan DH (2010) Langerhans cells: not your average dendritic cell. Trends
Immunol 31: 437.
22. Kaplan DH (2010) In vivo function of Langerhans cells and dermal dendritic
cells. Trends Immunol 31: 446-451.
23. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ (2005)
Epidermal langerhans cell-deficient mice develop enhanced contact
hypersensitivity. Immunity 23: 611-620.
24. Sato A, Takeda A (2012) Evaluation of efficacy and safety of finasteride 1 mg in
3177 Japanese men with androgenetic alopecia. J Dermatol 39: 27-32.
25. Price VH (1999) Treatment of hair loss. N Engl J Med 341: 964-973.
26. Rogers NE, Avram MR (2008) Medical treatments for male and female pattern
hair loss. J Am Acad Dermatol 59: 547-566.
27. Zouboulis CC, Degitz K (2004) Androgen action on human skin -- from basic
research to clinical significance. Exp Dermatol 13 Suppl 4: 5-10.
28. Olsen EA, Messenger AG, Shapiro J, Bergfeld WF, Hordinsky MK, et al. (2005)
Evaluation and treatment of male and female pattern hair loss. J Am Acad
Dermatol 52: 301-311.
29. Cotsarelis G, Millar SE (2001) Towards a molecular understanding of hair loss
and its treatment. Trends Mol Med 7: 293-301.
30. Whiting DA, Waldstreicher J, Sanchez M, Kaufman KD (1999) Measuring
reversal of hair miniaturization in androgenetic alopecia by follicular counts in
Citation: Takeda A, Sato A, Zhang L, Harti S, Cauwenbergh G, et al. (2013) CG210 Enables Finasteride 1mg Users to Further Improve Hair Pattern:
A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Hair Ther Transplant 3: 107. doi:10.4172/2167-0951.1000107
Page 5 of 5
Hair Ther Transplant Volume 3 ¢ Issue 1 ¢ 1000107
ISSN: 2167-0951 HTT, an open access journal
horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment
of men and postmenopausal women. J Investig Dermatol Symp Proc 4: 282-
284.
31. Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W (2001) beta-
Catenin controls hair follicle morphogenesis and stem cell differentiation in the
skin. Cell 105: 533-545.
32. Ahluwalia GS (2009) Cosmetic applications of laser & light-based systems.
Personal care and cosmetic technology, Norwich, NY: William Andrew Inc.
33. Prodi DA, Pirastu N, Maninchedda G, Sassu A, Picciau A, et al. (2008) EDA2R
is associated with androgenetic alopecia. J Invest Dermatol 128: 2268-2270.
34. Küster W, Happle R (1984) The inheritance of common baldness: two B or not
two B? J Am Acad Dermatol 11: 921-926.
35. Raskin CA (1997) Apoptosis and cutaneous biology. J Am Acad Dermatol 36:
885-896.
36. Paus R, Cotsarelis G (1999) The biology of hair follicles. N Engl J Med 341:
491-497.
37. Klemp P, Peters K, Hansted B (1989) Subcutaneous blood flow in early male
pattern baldness. J Invest Dermatol 92: 725-726.
38. Majno, Joris GI (2004) Cells, tissues, and disease : principles of general
pathology. (2nd edtn), Oxford: Oxford University Press. xxviii, 1005, New York .
39. Brown SB, Savill J (1999) Phagocytosis triggers macrophage release of Fas
ligand and induces apoptosis of bystander leukocytes. J Immunol 162: 480-
485.
40. Lucas M, Stuart LM, Savill J, Lacy-Hulbert A (2003) Apoptotic cells and innate
immune stimuli combine to regulate macrophage cytokine secretion. J Immunol
171: 2610-2615.
41. Lu PJ, Lu QL, Rughetti A, Taylor-Papadimitriou J (1995) bcl-2 overexpression
inhibits cell death and promotes the morphogenesis, but not tumorigenesis of
human mammary epithelial cells. J Cell Biol 129: 1363-1378.
topical L-carnitin-L-tartrate promotes human hair growth in vivo. J Dermatol
Sci 48: 141-144.
7. de Lacharrière O, Deloche C, Misciali C, Piraccini BM, Vincenzi C, et al. (2001)
Hair diameter diversity: a clinical sign reflecting the follicle miniaturization. Arch
Dermatol 137: 641-646.
8. Stenn KS, Eilertsen K (1996) Molecular basis of hair growth control. J Invest
Dermatol 107: 669-670.
9. Chang CH, Tsai RK, Yu HS (2005) Apoptosis coordinates with proliferation
and differentiation during human hair follicle morphogenesis. J Dermatol Sci
39: 9-16.
10. Winiarska A, Mandt N, Kamp H, Hossini A, Seltmann H, et al. (2006) Effect of
5alpha-dihydrotestosterone and testosterone on apoptosis in human dermal
papilla cells. Skin Pharmacol Physiol 19: 311-321.
11. Foitzik K, Hoting E, Förster T, Pertile P, Paus R (2007) L-carnitine-L-tartrate
promotes human hair growth in vitro. Exp Dermatol 16: 936-945.
12. Hibino T, Nishiyama T (2004) Role of TGF-beta2 in the human hair cycle. J
Dermatol Sci 35: 9-18.
13. Teraki Y, Shiohara T (1999) Apoptosis and the skin. Eur J Dermatol 9: 413-425.
14. Yunis JJ, Oken MM, Kaplan ME, Ensrud KM, Howe RR, et al. (1982) Distinctive
chromosomal abnormalities in histologic subtypes of non-Hodgkin s lymphoma.
N Engl J Med 307: 1231-1236.
15. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, et al. (1985)
Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering
around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:
899-906.
16. Cleary ML, Smith SD, Sklar J (1986) Cloning and structural analysis of cDNAs
for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18)
translocation. Cell 47: 19-28.
17. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM (1984) Cloning of the
chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome
translocation. Science 226: 1097-1099.
18. Jiang X, Wang X (2000) Cytochrome c promotes caspase-9 activation by
inducing nucleotide binding to Apaf-1. J Biol Chem 275: 31199-31203.
19. Cucé LC, C.J.a.R.C., Cellium GC (2011) evaluation of a new natural active
ingredient in 210 mg/ml topical solution, through scalp biopsy. Surg Cosmet
Dermatol 3: 123-128.
20. Trüeb RM (2002) Molecular mechanisms of androgenetic alopecia. Exp
Gerontol 37: 981-990.
21. Kaplan DH (2010) Langerhans cells: not your average dendritic cell. Trends
Immunol 31: 437.
22. Kaplan DH (2010) In vivo function of Langerhans cells and dermal dendritic
cells. Trends Immunol 31: 446-451.
23. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ (2005)
Epidermal langerhans cell-deficient mice develop enhanced contact
hypersensitivity. Immunity 23: 611-620.
24. Sato A, Takeda A (2012) Evaluation of efficacy and safety of finasteride 1 mg in
3177 Japanese men with androgenetic alopecia. J Dermatol 39: 27-32.
25. Price VH (1999) Treatment of hair loss. N Engl J Med 341: 964-973.
26. Rogers NE, Avram MR (2008) Medical treatments for male and female pattern
hair loss. J Am Acad Dermatol 59: 547-566.
27. Zouboulis CC, Degitz K (2004) Androgen action on human skin -- from basic
research to clinical significance. Exp Dermatol 13 Suppl 4: 5-10.
28. Olsen EA, Messenger AG, Shapiro J, Bergfeld WF, Hordinsky MK, et al. (2005)
Evaluation and treatment of male and female pattern hair loss. J Am Acad
Dermatol 52: 301-311.
29. Cotsarelis G, Millar SE (2001) Towards a molecular understanding of hair loss
and its treatment. Trends Mol Med 7: 293-301.
30. Whiting DA, Waldstreicher J, Sanchez M, Kaufman KD (1999) Measuring
reversal of hair miniaturization in androgenetic alopecia by follicular counts in
Citation: Takeda A, Sato A, Zhang L, Harti S, Cauwenbergh G, et al. (2013) CG210 Enables Finasteride 1mg Users to Further Improve Hair Pattern:
A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Hair Ther Transplant 3: 107. doi:10.4172/2167-0951.1000107
Page 5 of 5
Hair Ther Transplant Volume 3 ¢ Issue 1 ¢ 1000107
ISSN: 2167-0951 HTT, an open access journal
horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment
of men and postmenopausal women. J Investig Dermatol Symp Proc 4: 282-
284.
31. Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W (2001) beta-
Catenin controls hair follicle morphogenesis and stem cell differentiation in the
skin. Cell 105: 533-545.
32. Ahluwalia GS (2009) Cosmetic applications of laser & light-based systems.
Personal care and cosmetic technology, Norwich, NY: William Andrew Inc.
33. Prodi DA, Pirastu N, Maninchedda G, Sassu A, Picciau A, et al. (2008) EDA2R
is associated with androgenetic alopecia. J Invest Dermatol 128: 2268-2270.
34. Küster W, Happle R (1984) The inheritance of common baldness: two B or not
two B? J Am Acad Dermatol 11: 921-926.
35. Raskin CA (1997) Apoptosis and cutaneous biology. J Am Acad Dermatol 36:
885-896.
36. Paus R, Cotsarelis G (1999) The biology of hair follicles. N Engl J Med 341:
491-497.
37. Klemp P, Peters K, Hansted B (1989) Subcutaneous blood flow in early male
pattern baldness. J Invest Dermatol 92: 725-726.
38. Majno, Joris GI (2004) Cells, tissues, and disease : principles of general
pathology. (2nd edtn), Oxford: Oxford University Press. xxviii, 1005, New York .
39. Brown SB, Savill J (1999) Phagocytosis triggers macrophage release of Fas
ligand and induces apoptosis of bystander leukocytes. J Immunol 162: 480-
485.
40. Lucas M, Stuart LM, Savill J, Lacy-Hulbert A (2003) Apoptotic cells and innate
immune stimuli combine to regulate macrophage cytokine secretion. J Immunol
171: 2610-2615.
41. Lu PJ, Lu QL, Rughetti A, Taylor-Papadimitriou J (1995) bcl-2 overexpression
inhibits cell death and promotes the morphogenesis, but not tumorigenesis of
human mammary epithelial cells. J Cell Biol 129: 1363-1378.
H
habemus
Valued member
E
eddysimpson
Member
Hi,
Always prefer best quality natural hair care products otherwise low quality products can cause of hair loss.
Always prefer best quality natural hair care products otherwise low quality products can cause of hair loss.
H
habemus
Valued member
friends,
Soon I will put new pictures of progress with this lotion.
In December I will change treatment and inform which product will include.
greetings,
H
habemus
Valued member
I'll see if I can trade for one regrowth better with this lotion:
http://www.laboratoriosthea.com/arch...df/00098-2.pdf
Contains an ingredient said to be superior to finasteride in 31%, being of vegetable origin.
Give it a try! ..
Next week, on 1 November, I will start with new treatment:
Kaidax Spray con Tricoxidil.
Tricoxidil
¢ Increased VEGF synthesis and promotes angiogenesis (Lupinus albus)
¢ Promotes microcirculation by vasodilatation (Apigenin and
Complex homotaurine).
Att,
http://www.laboratoriosthea.com/arch...df/00098-2.pdf
Contains an ingredient said to be superior to finasteride in 31%, being of vegetable origin.
Give it a try! ..
Next week, on 1 November, I will start with new treatment:
Kaidax Spray con Tricoxidil.
Tricoxidil
¢ Increased VEGF synthesis and promotes angiogenesis (Lupinus albus)
¢ Promotes microcirculation by vasodilatation (Apigenin and
Complex homotaurine).
Att,
H
habemus
Valued member
The product is very pleasant and easy of using.
100ml in bottle. It gives for 1/5 month using 1x day like recommended.
Opportunely I will put image of the evolution.
att,
100ml in bottle. It gives for 1/5 month using 1x day like recommended.
Opportunely I will put image of the evolution.
att,
H
habemus
Valued member
http://img209.imageshack.us/img209/8391/h57u.jpg
Hi,
Do I see an evolution of the vellus with this new treatment, no?
Att,
Hi,
Do I see an evolution of the vellus with this new treatment, no?
Att,
H
habemus
Valued member
bullitnut
4 awesome repairs with SMG
Has anyone else used this CG210
On their site its states that it was presented at the International Society for Hair
Restoration Surgery (2012)
CG210 is an innovative worldwide patented topical product addressing excessive hair loss in men and women. The anti-hair loss efficacy and the excellent safety profile of CG210 have been proven clinically in subjects suffering from Male or Female Pattern Hair Loss [MPHL or AGA (Androgenetic Alopecia) and FPHL, respectively].CG210 is composed of natural botanical extracts, manufactured in France under GMP conditions. It is hypoallergenic and paraben free. Long-term application of CG210 is safe, has no side effect and no contraindications.
Studies in human scalp biopsies have shown that topical application of CG210 provides with a new promising approach to restore normal hair cycle and to stimulate hair regrowth by acting on three key aspects particularly relevant to excessive hair loss:
- Positive regulation of the intracellular anti-apoptosis protein (normalization of cell death process)
- Significant reduction of the micro-inflammatory conditions in the scalp
- Significant increase of collagen content and collagen remodeling.
Thanks to the actions of CG210 at the above-mentioned three levels, we observed in the CG210 users significantly improved hair retention and hair regrowth, as summarized in the following (clinical outcome evaluated using Phototrichogram technology):
- Hair loss rate returned to normal level in less than 44 days (quick improvement of Anagen/Telogen ratio in 80% of subjects)
- 8 200 new anagen hairs on average over the whole scalp in less than 3 months
- In long-term finasteride 1mg users, when the beneficial effects of finasteride reached the maximum level, the subjects who applied CG210 obtained an additional increase of 36.9% in hair diameter
[align=left]
[/align]
On their site its states that it was presented at the International Society for Hair
Restoration Surgery (2012)
CG210 is an innovative worldwide patented topical product addressing excessive hair loss in men and women. The anti-hair loss efficacy and the excellent safety profile of CG210 have been proven clinically in subjects suffering from Male or Female Pattern Hair Loss [MPHL or AGA (Androgenetic Alopecia) and FPHL, respectively].CG210 is composed of natural botanical extracts, manufactured in France under GMP conditions. It is hypoallergenic and paraben free. Long-term application of CG210 is safe, has no side effect and no contraindications.
Studies in human scalp biopsies have shown that topical application of CG210 provides with a new promising approach to restore normal hair cycle and to stimulate hair regrowth by acting on three key aspects particularly relevant to excessive hair loss:
- Positive regulation of the intracellular anti-apoptosis protein (normalization of cell death process)
- Significant reduction of the micro-inflammatory conditions in the scalp
- Significant increase of collagen content and collagen remodeling.
Thanks to the actions of CG210 at the above-mentioned three levels, we observed in the CG210 users significantly improved hair retention and hair regrowth, as summarized in the following (clinical outcome evaluated using Phototrichogram technology):
- Hair loss rate returned to normal level in less than 44 days (quick improvement of Anagen/Telogen ratio in 80% of subjects)
- 8 200 new anagen hairs on average over the whole scalp in less than 3 months
- In long-term finasteride 1mg users, when the beneficial effects of finasteride reached the maximum level, the subjects who applied CG210 obtained an additional increase of 36.9% in hair diameter
[align=left]
[/align]
H
habemus
Valued member
H
habemus
Valued member
H
habemus
Valued member
Bigmac
Administrator
Staff member
Nice to hear your hair is improving, thanks for the updates.
H
habemus
Valued member
H
habemus
Valued member
H
habemus
Valued member
This sequence of images shows some progress.
https://imageshack.com/i/f29pgdj
or this
http://haircut.portugueseforum.net/t10-imagens-de-evolucao
Att,
https://imageshack.com/i/f29pgdj
or this
http://haircut.portugueseforum.net/t10-imagens-de-evolucao
Att,
Last edited:
H
habemus
Valued member
H
habemus
Valued member
¬b`
http://haircut.portugueseforum.net/t10-imagens-de-evolucao
http://haircut.portugueseforum.net/t10-imagens-de-evolucao
